Trial SAKK 66/18 is investigating a new type of therapy for patients with B-cell non-Hodgkin’s lymphoma who have suffered a recurrence or proven to be therapy-resistant following standard treatments.

The combination of copanlisib (Aliqopa™) and venetoclax (Venclyxto™) is examined, as it is thought that this may produce synergistic effects.

For more information on where and how this trial is conducted, consult the trial website.